CY-503 for the Treatment of Chemotherapy-refractory Metastatic Colorectal Cancer
- First Posted Date
- 2009-07-03
- Last Posted Date
- 2013-07-10
- Lead Sponsor
- Cytavis Biopharma GmbH
- Target Recruit Count
- 77
- Registration Number
- NCT00932724
- Locations
- 🇦🇹
Bezirkskrankenhaus Hall, Hall in Tirol, Austria
🇦🇹St. Vinzenz Krankenhaus Zams, Zams, Austria
🇩🇪Onkologische Schwerpunktpraxis, Hof, Germany
CY503 for the Treatment of Malignant Melanoma Stage IV After Failure of Prior Therapy
Phase 2
Completed
- Conditions
- Melanoma
- First Posted Date
- 2008-04-15
- Last Posted Date
- 2011-06-08
- Lead Sponsor
- Cytavis Biopharma GmbH
- Target Recruit Count
- 31
- Registration Number
- NCT00658437
- Locations
- 🇩🇪
Haut Tumor Zentrum Charité, Berlin, Germany
🇩🇪Dermatologisches Zentrum Elbe-Klinikum Buxtehude, Buxtehude, Germany
🇩🇪Universitäts-Hautklinik Kiel, Kiel, Germany
© Copyright 2025. All Rights Reserved by MedPath